Alpha Teknova (TKNO) Aktievy
Alpha Teknova, Inc. producerar viktiga reagenser för upptäckt, utveckling och kommersialisering av nya terapier, vacciner och molekylär diagnostik i USA och internationellt. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 2/6 |
| Framtida tillväxt | 1/6 |
| Tidigare resultat | 0/6 |
| Finansiell hälsa | 6/6 |
| Utdelningar | 0/6 |
TKNO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Alpha Teknova, Inc. Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$3.51 |
| 52 veckors högsta | US$6.86 |
| 52 veckors lägsta | US$1.91 |
| Beta | 0.47 |
| 1 månads förändring | 28.10% |
| 3 månaders förändring | 75.50% |
| 1 års förändring | -46.94% |
| 3 års förändring | 64.02% |
| 5 års förändring | n/a |
| Förändring sedan börsintroduktionen | -85.96% |
Senaste nyheter och uppdateringar
Analysartikel • May 09
Analyst Estimates: Here's What Brokers Think Of Alpha Teknova, Inc. (NASDAQ:TKNO) After Its First-Quarter Report
Alpha Teknova, Inc. ( NASDAQ:TKNO ) defied analyst predictions to release its quarterly results, which were ahead of...
Uppdatering av berättelse • Apr 28
TKNO: Long Term Revenue Guidance Will Support Future Upside Potential
Analysts have adjusted their price target on Alpha Teknova to $7.00 per share from $7.00, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, with an expected total revenue range of $42 million to $44 million (company guidance).Uppdatering av berättelse • Apr 12
TKNO: Long Term Revenue Guidance And Higher P/E Will Support Future Upside
Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7.00, reflecting updated views on discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating an expected total revenue range of $42 million to $44 million.Recent updates
Analysartikel • May 09
Analyst Estimates: Here's What Brokers Think Of Alpha Teknova, Inc. (NASDAQ:TKNO) After Its First-Quarter Report
Alpha Teknova, Inc. ( NASDAQ:TKNO ) defied analyst predictions to release its quarterly results, which were ahead of...Uppdatering av berättelse • Apr 28
TKNO: Long Term Revenue Guidance Will Support Future Upside Potential
Analysts have adjusted their price target on Alpha Teknova to $7.00 per share from $7.00, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, with an expected total revenue range of $42 million to $44 million (company guidance).Uppdatering av berättelse • Apr 12
TKNO: Long Term Revenue Guidance And Higher P/E Will Support Future Upside
Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7.00, reflecting updated views on discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating an expected total revenue range of $42 million to $44 million.Uppdatering av berättelse • Mar 26
TKNO: Long Term Revenue Guidance Will Support Future Upside Potential
Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that leave their fair value view essentially unchanged. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating expected total revenue in a range of $42 million to $44 million.Uppdatering av berättelse • Mar 11
TKNO: Updated Revenue Outlook Will Support Future Upside Potential
Analysts have trimmed their price target on Alpha Teknova to $7.00 from $7 as they factor in updated assumptions for the discount rate, revenue growth, profit margin and future P/E. Their view remains broadly aligned with prior estimates while they fine tune the model inputs.Uppdatering av berättelse • Feb 25
TKNO: Steady Fair Value Anchor Will Support Future Upside Potential
Analysts have trimmed their price target on Alpha Teknova to $7.00 from $7 as they adjust assumptions around discount rates, revenue growth, profit margins, and future P/E. This reflects updated views on the company’s risk profile and earnings potential.Uppdatering av berättelse • Feb 10
TKNO: Steady Fair Value Anchor Will Support Future Upside Potential
Narrative Update on Alpha Teknova Analysts have kept their fair value estimate for Alpha Teknova broadly steady at about $7.00. They explain that modest tweaks to assumptions, such as a slightly higher discount rate, small adjustments to revenue growth and profit margin outlooks, and a marginally lower future P/E, leave their overall price target view essentially unchanged.Uppdatering av berättelse • Jan 27
TKNO: Earnings Guidance And Tuck In Deals Will Support Future Upside
Analysts have nudged their price target on Alpha Teknova slightly higher, citing updated assumptions around discount rates, revenue growth of about 17.6% and a future P/E near 46.1x to support a modestly refined fair value estimate of about $7.00 per share. What's in the News Alpha Teknova reiterated earnings guidance for the fiscal year ending December 31, 2025, with total revenue still expected in the range of $39 million to $42 million.Analysartikel • Jan 18
Alpha Teknova, Inc.'s (NASDAQ:TKNO) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 29% in the last...Uppdatering av berättelse • Jan 13
TKNO: Earnings Guidance And Tuck In Deals Will Drive Future Upside
Analysts have modestly adjusted their price target on Alpha Teknova, citing an updated fair value of $7.00, a slightly higher discount rate, revised revenue growth expectations to 17.46%, a small change in the assumed profit margin, and a lower future P/E estimate of 46.25x. What's in the News Alpha Teknova reiterated earnings guidance for the fiscal year ending December 31, 2025, with expected total revenue in a range of $39 million to $42 million.Uppdatering av berättelse • Dec 27
TKNO: Earnings Guidance And Tuck In Deals Will Support Future Upside
Narrative Update: Alpha Teknova Analysts have modestly raised their price target on Alpha Teknova by approximately $1.00 per share, reflecting slightly higher assumptions for long term revenue growth and profit margins. This is partially offset by a marginally higher discount rate and a small reduction in projected future P E multiples.Uppdatering av berättelse • Dec 13
TKNO: Earnings Guidance And M&A Efforts Will Support Future Upside Potential
Analysts have trimmed their price target for Alpha Teknova from 8 dollars to 7 dollars, citing slightly slower expected revenue growth and a higher perceived discount rate, despite modestly better margin and valuation assumptions. What's in the News Reiterated 2025 earnings guidance, maintaining projected total revenue in the range of 39 million dollars to 42 million dollars for the year ending December 31, 2025 (company guidance).Analysartikel • Nov 12
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.00
Alpha Teknova, Inc. ( NASDAQ:TKNO ) just released its quarterly report and things are looking bullish. Results overall...Analysartikel • Sep 25
Alpha Teknova, Inc.'s (NASDAQ:TKNO) P/S Is Still On The Mark Following 27% Share Price Bounce
Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have had a really impressive month, gaining 27% after a shaky period...Analysartikel • Jul 22
Alpha Teknova, Inc.'s (NASDAQ:TKNO) 26% Cheaper Price Remains In Tune With Revenues
To the annoyance of some shareholders, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares are down a considerable 26% in the...Analysartikel • Jun 11
Shareholders Will Probably Not Have Any Issues With Alpha Teknova, Inc.'s (NASDAQ:TKNO) CEO Compensation
Key Insights Alpha Teknova will host its Annual General Meeting on 17th of June CEO Stephen Gunstream's total...
Ny berättelse • Mar 29
Acquisitions And Collaborations Will Expand Cell And Gene Therapy Portfolio
Expansion through collaborations and acquisitions aims to boost top-line growth, margins, and financial stability amidst anticipated market rebound.Analysartikel • Mar 06
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets
Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders are probably feeling a little disappointed, since its shares fell 9.3...Analysartikel • Feb 28
Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing
Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders won't be pleased to see that the share price has had a very rough...Analysartikel • Feb 23
Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO)
Key Insights The projected fair value for Alpha Teknova is US$8.71 based on 2 Stage Free Cash Flow to Equity With...Analysartikel • Dec 14
Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 28%
Despite an already strong run, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have been powering on, with a gain of 28% in...Analysartikel • Oct 15
Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 42%
Despite an already strong run, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have been powering on, with a gain of 42% in...Analysartikel • Jun 27
Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%
Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 30% in the last...Analysartikel • Apr 24
Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%
To the annoyance of some shareholders, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares are down a considerable 25% in the...Analysartikel • Jan 22
Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysartikel • Aug 14
Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates
Market forces rained on the parade of Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders today, when the analysts...Analysartikel • Apr 17
Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper
Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 30% in the last...Analysartikel • May 14
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target
As you might know, Alpha Teknova, Inc. ( NASDAQ:TKNO ) just kicked off its latest quarterly results with some very...Aktieägarnas avkastning
| TKNO | US Life Sciences | US Marknad | |
|---|---|---|---|
| 7D | -8.4% | -5.8% | -0.9% |
| 1Y | -46.9% | -1.1% | 24.4% |
Avkastning vs industri: TKNO presterade sämre än US Life Sciences branschen som gav -1.1 % under det senaste året.
Avkastning vs Marknaden: TKNO presterade sämre än US marknaden som gav 24.4 % under det senaste året.
Prisvolatilitet
| TKNO volatility | |
|---|---|
| TKNO Average Weekly Movement | 12.7% |
| Life Sciences Industry Average Movement | 8.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: TKNO s aktiekurs har varit volatil under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: TKNO s veckovolatilitet ( 13% ) har varit stabil under det senaste året, men är fortfarande högre än 75 % av US aktier.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1996 | 158 | Stephen Gunstream | www.teknova.com |
Alpha Teknova, Inc. producerar viktiga reagenser för upptäckt, utveckling och kommersialisering av nya terapier, vacciner och molekylär diagnostik i USA och internationellt. Företagets primära produkter inkluderar förgjutna medieplattor för celltillväxt och kloning, flytande mikrobiella odlingsmedier och kosttillskott för cellulär expansion samt molekylärbiologiska reagenser för provhantering, resuspension och rening. Företaget tillhandahåller även lab essentials, som är kemiska formuleringar för användning inom biologisk forskning och läkemedelsutveckling, samt clinical solutions, en anpassad produkt som används vid utveckling och produktion av proteinterapier, genterapier, mRNA-vacciner och diagnostiska kit.
Alpha Teknova, Inc. Sammanfattning av grunderna
| TKNO grundläggande statistik | |
|---|---|
| Börsvärde | US$199.44m |
| Vinst(TTM) | -US$17.17m |
| Intäkter(TTM) | US$41.80m |
4.5x
P/S-förhållande-11.0x
P/E-förhållandeÄr TKNO övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| TKNO resultaträkning (TTM) | |
|---|---|
| Intäkter | US$41.80m |
| Kostnad för intäkter | US$27.58m |
| Bruttovinst | US$14.22m |
| Övriga kostnader | US$31.39m |
| Intäkter | -US$17.17m |
Senast redovisade vinst
Mar 31, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | -0.32 |
| Bruttomarginal | 34.01% |
| Nettovinstmarginal | -41.07% |
| Skuld/egenkapitalförhållande | 20.3% |
Hur har TKNO utvecklats på lång sikt?
Se historisk utveckling och jämförelseFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/15 11:21 |
| Aktiekurs vid dagens slut | 2026/05/15 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Alpha Teknova, Inc. bevakas av 7 analytiker. 6 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Mark Massaro | BTIG |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Paul Knight | KeyBanc Capital Markets Inc. |